Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis

dc.contributor.authorKichloo, Asim
dc.contributor.authorEl-amir, Zain
dc.contributor.authorAucar, Maria
dc.contributor.authorDahiya, Dushyant Singh
dc.contributor.authorAl-Haddad, Mohammad
dc.contributor.authorPisipati, Sailaja
dc.contributor.authorBeiz, Hassan
dc.contributor.authorSingh, Gurdeep
dc.contributor.authorGandhi, Darshan
dc.contributor.authorSingh, Jagmeet
dc.contributor.authorPathappillil, Patrick
dc.contributor.authorMohideen, Haseeb
dc.contributor.authorShaka, Hafeez
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2023-05-17T12:26:31Z
dc.date.available2023-05-17T12:26:31Z
dc.date.issued2022
dc.description.abstractBackground: Hypertriglyceridemia (HTG) is a well-established cause of acute pancreatitis often leading to significant morbidity, mortality, and healthcare burden. This study aimed to describe the rate, reasons, and predictors of HTG-induced acute pancreatitis (HTG-AP) in the USA. Methods: This retrospective study analyzed the Nationwide Readmissions Database (NRD) for 2018 to determine all adults (≥ 18 years) readmitted within 30 days of an index hospitalization of HTG-AP. Hospitalization characteristics and adverse outcomes for 30-day readmissions were highlighted and compared with index admissions of HTG-AP. Furthermore, independent predictors for 30-day readmissions of HTG-AP were also identified. P values ≤ 0.05 were considered statistically significant. Results: In 2018, the rate of 30-day readmission of HTG-AP was noted to be 13.5%. At the time of readmission, AP (45.2%) was identified as the most common principal diagnosis, followed by chronic pancreatitis (6.3%) and unspecified sepsis (4.8%). Compared to index admissions, 30-day readmissions of HTG-AP had a higher proportion of patients with Charlson Comorbidity Index (CCI) scores ≥ 3 (48.5% vs. 33.8%, P < 0.001). Furthermore, we noted higher rates of inpatient mortality (1.7% vs. 0.7%, odds ratio (OR): 2.55, 95% confidence interval (CI): 1.83 - 3.57, P < 0.001), mean length of stay (LOS) (5.6 vs. 4.1 days, OR: 1.5, 95% CI: 1.2 - 1.7, P < 0.001), and mean total healthcare charge (THC) ($56,799 vs. $36,078, OR: 18,702, 95% CI: 15,136 - 22,267, P < 0.001) for 30-day readmissions of HTG-AP compared to index admissions. Independent predictors for 30-day all-cause readmissions of HTG-AP included hypertension, protein energy malnutrition (PEM), CCI scores ≥ 3, chronic kidney disease and discharge against medical advice. Conclusions: AP was the principal diagnosis on presentation in only 45.2% patients for 30-day readmissions of HTG-AP. Compared to index admissions, 30-day readmissions of HTG-AP had a higher comorbidity burden, inpatient mortality, mean LOS and mean THC.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationKichloo A, El-Amir Z, Aucar M, et al. Clinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitis. Gastroenterology Res. 2022;15(1):19-25. doi:10.14740/gr1484en_US
dc.identifier.urihttps://hdl.handle.net/1805/33033
dc.language.isoen_USen_US
dc.publisherElmer Pressen_US
dc.relation.isversionof10.14740/gr1484en_US
dc.relation.journalGastroenterology Researchen_US
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0*
dc.sourcePMCen_US
dc.subjectReadmissionsen_US
dc.subjectHypertriglyceridemiaen_US
dc.subjectAcute pancreatitisen_US
dc.subjectOutcomesen_US
dc.subjectMortalityen_US
dc.titleClinical Outcomes and Predictors of Thirty-Day Readmissions of Hypertriglyceridemia-Induced Acute Pancreatitisen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
gr-15-019.pdf
Size:
620.94 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: